» Articles » PMID: 22915618

Multiple Cytokines and Chemokines Are Associated with Rheumatoid Arthritis-related Autoimmunity in First-degree Relatives Without Rheumatoid Arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)

Abstract

Objective: We investigated whether rheumatoid arthritis (RA)-related autoantibodies were associated with systemic inflammation in a prospective cohort of first-degree relatives (FDRs) of RA probands, a population without RA but at increased risk for its future development.

Methods: We studied 44 autoantibody positive FDRs, of whom 29 were rheumatoid factor (RF) positive, 25 were positive for the high risk autoantibody profile (HRP), that is, positive for anti-cyclic citrullinated peptide and/or for at least two RF IgM, IgG or IgA isotypes, and nine FDRs who were positive for both; and 62 FDRs who were never autoantibody positive. Twenty-five cytokines/chemokines were measured using a bead-based assay in serum. As a comprehensive measure of inflammation, we calculated a Cytokine Score by summing all cytokine/chemokine levels, weighted by their regression coefficients for RA-autoantibody association. We compared C-reactive protein, individual cytokines/chemokines and Cytokine Score to the outcomes: positivity for RF and for the HRP using logistic regression.

Results: Adjusting for age, sex, ethnicity and ever smoking, the Cytokine Score and levels of IL-6 and IL-9 were associated with both RF and HRP. IL-2, granulocyte macrophage-colony stimulating factor (GM-CSF), and interferon (IFN)-γ were associated with HRP only. Associations between the Cytokine Score and RF and HRP positivity were replicated in an independent military personnel cohort.

Conclusions: In first-degree relatives of patients with RA, RA-related autoimmunity is associated with inflammation, as evidenced by associations with multiple cytokines and chemokines.

Citing Articles

Targeting the serum marker interleukin 9 improves the underlying characterization and immune homeostasis in rheumatoid arthritis.

Xiong Y, Xiang W, Xiao W Cent Eur J Immunol. 2024; 49(2):132-146.

PMID: 39381556 PMC: 11457572. DOI: 10.5114/ceji.2024.141695.


Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review.

Khokhar M, Dey S, Tomo S, Jaremko M, Emwas A, Pandey R ACS Pharmacol Transl Sci. 2024; 7(6):1664-1693.

PMID: 38898941 PMC: 11184612. DOI: 10.1021/acsptsci.4c00067.


Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).

Hughes-Austin J, Katz R, Majka D, Criqui M, Robinson W, Firestein G PLoS One. 2023; 18(10):e0291967.

PMID: 37874814 PMC: 10597499. DOI: 10.1371/journal.pone.0291967.


Macrophage's role in solid tumors: two edges of a sword.

Jahandideh A, Yarizadeh M, Masjedi M, Fatehnejad M, Jahandideh R, Soheili R Cancer Cell Int. 2023; 23(1):150.

PMID: 37525217 PMC: 10391843. DOI: 10.1186/s12935-023-02999-3.


Beneficial Effect of Infection on the Prognosis of Breast Cancer Was Modified by Cytokines.

Ye H, Lu M, Liu Q, Lin Y, Tang L, Ren Z Clin Epidemiol. 2023; 15:469-481.

PMID: 37122480 PMC: 10145453. DOI: 10.2147/CLEP.S408182.


References
1.
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van Venrooij W . A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004; 6(4):R303-8. PMC: 464874. DOI: 10.1186/ar1187. View

2.
Khan I, Krishnan V, Ziman M, Janatpour K, Wun T, Luciw P . A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom. 2008; 76(3):159-68. PMC: 4425447. DOI: 10.1002/cyto.b.20452. View

3.
Nielen M, van Schaardenburg D, Reesink H, Twisk J, van de Stadt R, van der Horst-Bruinsma I . Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis. 2005; 65(4):535-7. PMC: 1798080. DOI: 10.1136/ard.2005.040659. View

4.
Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R . Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000; 27(12):2743-6. View

5.
Aho K, Palusuo T, Kurki P . Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications. Semin Arthritis Rheum. 1994; 23(6):379-87. DOI: 10.1016/0049-0172(94)90088-4. View